Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal hydromorphone for postoperative pain after arthroscopic ACL reconstruction
ChiCTR1800015438Phase 4Not yet recruiting
- Sponsor
- The University of Hong Kong-Shenzhen Hospital
- Start
- Apr 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydromorphone and bupivacaine in postoperative pain (2 arms), sponsored by The University of Hong Kong-Shenzhen Hospital. Primary endpoints: Pain score and Adverse effect. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
hydromorphonebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1800015438.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800015438.